Securities Analyst Recommendations: Fuwei Films (Holdings) Co., Ltd. (FFHL), Applied Genetic Technologies Corporation (AGTC)

Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL) tinted gains of +5.26% (+0.11 points) to US$2.2. The volume of 0.14 Million shares climbed down over an trading activity of 41.19 Million shares. EPS ratio determined by looking at last 12 month figures is -1.32. Over the same time span, the stock marked US$4.65 as its best level and the lowest price reached was US$1.7. The corporation has a market cap of US$7.37 Million.

Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL)’s earnings per share has been growing at a 3.3 percent rate over the past 5 year when average revenue increase was noted as -4.9 percent. The return on equity ratio or ROE stands at -13.8 percent while most common profitability ratio return on investment (ROI) was -7.1 percent. The company’s institutional ownership is monitored at 4.2 percent. The company’s net profit margin has achieved the current level of -8.9 percent and possesses 14 percent gross margin.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) is worth US$73.29 Million and has recently risen 5.14% to US$4.09. The latest exchange of 0.14 Million shares is below its average trading activity of 146.85 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$7.5 while the mean 12-month price target for the shares is US$8.35.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0.98, and a price to sales ratio of 2.53. For the past 5 years, the company’s revenue has grown 91.4%, while the company’s earnings per share has grown -25.6%. With an institutional ownership near 50.8%, it carries an earnings per share ratio of -0.98.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 2 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.